![Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care - eClinicalMedicine Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/61e1346b-cb76-481f-a75f-ee760230a8dd/gr1_lrg.jpg)
Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care - eClinicalMedicine
![Frontiers | Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects | Pharmacology Frontiers | Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects | Pharmacology](https://www.frontiersin.org/files/Articles/709349/fphar-12-709349-HTML-r1/image_m/fphar-12-709349-g001.jpg)
Frontiers | Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects | Pharmacology
![Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator | Psychological Medicine | Cambridge Core Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator | Psychological Medicine | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210317072048621-0876:S0033291718002738:S0033291718002738_tab1.gif?pub-status=live)
Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator | Psychological Medicine | Cambridge Core
![Frontiers | Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study | Psychiatry Frontiers | Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study | Psychiatry](https://www.frontiersin.org/files/Articles/736822/fpsyt-12-736822-HTML/image_m/fpsyt-12-736822-t002.jpg)
Frontiers | Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study | Psychiatry
![Atypical antipsychotic use in children and adolescents (age 4–18 years). | Download Scientific Diagram Atypical antipsychotic use in children and adolescents (age 4–18 years). | Download Scientific Diagram](https://www.researchgate.net/profile/Minji-Sohn-2/publication/303893542/figure/fig2/AS:372567375400962@1465838392443/Atypical-antipsychotic-use-in-children-and-adolescents-age-4-18-years.png)
Atypical antipsychotic use in children and adolescents (age 4–18 years). | Download Scientific Diagram
![Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness - ScienceDirect Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0920996420300190-gr1.jpg)
Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness - ScienceDirect
![Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care - eClinicalMedicine Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d18ea8f1-ecfc-4064-aefd-bcd122f92756/gr2_lrg.jpg)
Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care - eClinicalMedicine
![Atypical antipsychotic use in children and adolescents (age 4\u201318... | Download Scientific Diagram Atypical antipsychotic use in children and adolescents (age 4\u201318... | Download Scientific Diagram](https://www.researchgate.net/profile/Minji-Sohn-2/publication/303893542/figure/fig4/AS:391164499906607@1470272292512/Atypical-antipsychotic-use-in-children-and-adolescents-age-4u201318-years_Q640.jpg)
Atypical antipsychotic use in children and adolescents (age 4\u201318... | Download Scientific Diagram
![Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database | European Psychiatry | Cambridge Core Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database | European Psychiatry | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200407075527788-0744:S0924933800259075:S0924933800259075_tab2.png?pub-status=live)
Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database | European Psychiatry | Cambridge Core
![Table 2 from An Audit of New Zealand's Intellectual Disability Specialty In-Patient Units: Focussing on Antipsychotic Medication Use | Semantic Scholar Table 2 from An Audit of New Zealand's Intellectual Disability Specialty In-Patient Units: Focussing on Antipsychotic Medication Use | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3e40ffd67eadf1db05aaaf27f0106e78478ca266/61-Table2-1.png)